[Summary] Committed to providing patients with affordable innovative mechanism-b
Shenzhen Chipscreen Biosciences Co., Ltd. (hereinafter referred to as "Chipscreen Biosciences", stock code: 688321.SH) is a modern biomedical enterprise founded in 2001 by a team of seasoned returnees from the United States. The company specializes in the research and development of original new molecular entity drugs, with comprehensive capabilities from target discovery and validation, lead molecule discovery and evaluation, to clinical development, industrialization, and commercialization of new drugs. It boasts a technical, management, and intellectual property team specializing in original innovative drug R&D.
We have independently created an internationally advanced "integrated drug discovery and early evaluation platform based on chemical genomics," and have utilized this platform to develop a series of original innovative drug product lines with global intellectual property protection across five major disease areas: oncology, metabolic diseases, autoimmune diseases, central nervous system diseases, and antiviral therapy. These include Chidamide (marketed), Chiglitazar Sodium (marketed), Chiauranib (Phase III clinical trial enrollment initiated), and CS12192 (entered Phase I clinical trials). We are a pioneer in the field of original innovative drugs in China.
We have a global industrial layout comprising the Shenzhen headquarters/R&D center/GMP production base, Chengdu regional headquarters/R&D center/GMP production base, Beijing clinical research and operations center, Shanghai commercial center, and Chipscreen Biosciences (USA) Co., Ltd. As one of the first national "Innovative Drug Incubation Bases" and a national high-tech enterprise, the company has independently undertaken multiple national major science and technology projects under the "863" Program, the "Tenth Five-Year", "Eleventh Five-Year", "Twelfth Five-Year", "Thirteenth Five-Year", and "Fourteenth Five-Year" plans, as well as the "Major New Drug Creation" program. It has cumulatively filed over 480 domestic and international invention patent applications, with more than 130 authorized.
What does Shenzhen Chipscreen Biosciences Co., Ltd. require? Who is Chipscreen Biosciences hiring? Chipscreen Biosciences recruitment: 医疗卫生/美容保健类占比最多占69.5%，其次是销售类占48.9%. What education can get in at Chipscreen Biosciences? 大专占比最多占37.3%，其次是本科占33%. High education required at Chipscreen Biosciences? 硕士占20.2%，博士占7.7%. Work experience required at Chipscreen Biosciences? 3-5年占比最多占38.2%，其次是1-3年占27.5%. Where are the job locations at Chipscreen Biosciences? 成都占比最多占22.3%，其次是深圳占15%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
